Long-Term Care Costs Are Eating Inheritances — Investment Opportunities in Elder Care

Opening hook: $19,179 and shrinking inheritances

The average American spent $19,179 in out-of-pocket long-term care costs in their final decade between 2006 and 2022, wiping out planned inheritances and shifting burdens onto Medicaid and families. That single figure explains why investors should stop treating elder care as a social problem and start treating it as a multi-trillion-dollar market shift.

What happened: out-of-pocket spending, longer lives, and stretched safety nets

Between 2006 and 2022 the typical decedent paid $19,179 in long-term care out-of-pocket in their last ten years of life, according to a major analysis. At the same time, the U.S. 65-plus population is on track to reach about 73 million by 2030, expanding the pool of potential care consumers by roughly 17 million versus 2020.

Costs are already high: Genworth’s 2022 Cost of Care survey showed median annual costs of about $108,405 for a private nursing home room and roughly $57,600 for assisted living. With lifespans lengthening and a caregiver shortage reducing supply, families are drawing down savings faster and increasingly leaning on Medicaid, which can trigger estate recovery for beneficiaries.

Why it matters: structural demand, price inflation, and fiscal spillovers

This is not a short-term cost shock, it’s a secular demand shock. The 65+ cohort will expand by roughly 30% from 2020 to 2030, while the workforce in direct care has grown far slower, producing upward pressure on prices. When supply is tight and demand rises 30%, providers with scalable, efficient delivery capture margins and market share.

Public budgets will feel it. Medicaid already funds nearly half of U.S. long-term care spending in some states, and rising enrollment shifts liabilities onto state balance sheets. For investors, that creates both macro risk and targeted opportunity: companies that reduce per-patient cost or shift care out of institutional settings can win if reimbursement follows proven savings.

We can draw historical precedent from the post-2000 shift to outpatient and home-based care in healthcare generally. When hospital-at-home models and outpatient clinics proved lower cost per episode, insurers and Medicare redirected flows. Long-term care is at a similar inflection point, except the incumbent facility model still receives most dollars despite higher per-day costs of $100,000-plus in nursing homes.

The bull case: scalable home care, Medicare Advantage, and asset-light plays

Winners will be those that capitalize on three trends: shifting care to the home, integrating care management into value-based plans, and owning specialized real estate with flexible use. Home-health providers such as Amedisys (AMED) and Addus HomeCare (ADUS) can expand revenue per patient while keeping fixed costs lower than nursing homes. If home care growth accelerates from mid-single digits to double digits annually, those companies can compound EBITDA above the sector average.

Insurers with Medicare Advantage scale, like Humana (HUM) and UnitedHealth Group (UNH), can profit by managing long-term care risk through care coordination. Medicare Advantage penetration in the 65+ market was about 50% in recent years; each percentage point of additional enrollment funnels billions from fee-for-service into outcomes-focused plans.

The bear case: reimbursement risk, regulatory pushback, and execution gaps

Policy and reimbursement can swing fast. States under fiscal stress may tighten Medicaid eligibility or slow payments, pressuring providers that depend on state-funded nursing home revenue. Nursing-home REITs such as Welltower (WELL) and Ventas (VTR) face asset-level risk if occupancy declines or Medicaid payments lag, potentially compressing funds from operations, which have historically ranged in the mid-single digits to low teens percent yields.

Operationally, scaling high-quality home care is hard. Labor intensity, high turnover, and thin initial margins mean providers must execute relentlessly. Genworth’s collapse into solvency concerns in past years shows how quickly long-term care finance can sour when liabilities are underpriced and longevity trends surprise insurers.

What this means for investors: where to position and specific tickers to watch

Investors should allocate with a barbell: growth exposure to home health and care management, plus selective real-estate and insurance plays hedged for policy risk. Three concrete allocations work:

• Home health operators: Amedisys (AMED) and Addus HomeCare (ADUS) offer direct exposure to growing in-home care demand. Target positions near 6-10% of a health allocation, size based on execution confidence, with stop-losses for margin compression.
• Care management and Medicare Advantage: Humana (HUM) and UnitedHealth (UNH) are leverage to shifting payment models. A 5-8% position can serve as durable beta in aging demographics, given MA enrollment is ~50% and rising.
• Selective REIT exposure: Welltower (WELL) and Ventas (VTR) can work if you favor asset-light senior housing and medical-office conversions, especially where occupancy can be repurposed. Keep size modest and prefer names with balance-sheet flexibility.

Short or avoid pure nursing-home operators with concentrated Medicaid exposure and weak balance sheets. Watch Genworth (GNW) and legacy long-term care insurers only as high-risk trades, not core holdings, unless you have deep expertise in actuarial repricing.

A reported $19,179 — the average out-of-pocket long-term care cost in the last decade of life, 2006-2022 (citation needed).

Actionable takeaway: pivot a portion of your health-care exposure toward scalable, home-first models and Medicare Advantage managers. Start with a 5-10% overweight to high-quality home-health operators (AMED, ADUS) and MA leaders (HUM, UNH), keep REIT exposure (WELL, VTR) tactical, and treat legacy LTC insurers (GNW) as speculative plays only after stress-testing downside scenarios. Aging is inevitable, costs are rising, and capital that adapts to care outside institutions will capture both growth and margin expansion.